391 related articles for article (PubMed ID: 33240092)
21. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases.
Tsuchiya A; Takeuchi S; Iwasawa T; Kumagai M; Sato T; Motegi S; Ishii Y; Koseki Y; Tomiyoshi K; Natsui K; Takeda N; Yoshida Y; Yamazaki F; Kojima Y; Watanabe Y; Kimura N; Tominaga K; Kamimura H; Takamura M; Terai S
Inflamm Regen; 2020; 40():14. PubMed ID: 32582401
[TBL] [Abstract][Full Text] [Related]
22. Possible mechanisms responsible for acute coronary events in COVID-19.
Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
[TBL] [Abstract][Full Text] [Related]
23. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.
Lupu L; Palmer A; Huber-Lang M
Front Immunol; 2020; 11():584514. PubMed ID: 33101314
[TBL] [Abstract][Full Text] [Related]
24. How COVID-19 induces cytokine storm with high mortality.
Hojyo S; Uchida M; Tanaka K; Hasebe R; Tanaka Y; Murakami M; Hirano T
Inflamm Regen; 2020; 40():37. PubMed ID: 33014208
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.
Shibabaw T
J Inflamm Res; 2020; 13():673-680. PubMed ID: 33116747
[TBL] [Abstract][Full Text] [Related]
26. The immune system and COVID-19: Friend or foe?
Yazdanpanah F; Hamblin MR; Rezaei N
Life Sci; 2020 Sep; 256():117900. PubMed ID: 32502542
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].
Zhang T; Sun LX; Feng RE
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jun; 43(6):496-502. PubMed ID: 32241072
[TBL] [Abstract][Full Text] [Related]
28. Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome.
Lin SH; Zhao YS; Zhou DX; Zhou FC; Xu F
Genes Dis; 2020 Dec; 7(4):520-527. PubMed ID: 32837983
[TBL] [Abstract][Full Text] [Related]
29. Mesenchymal stem cell therapy for COVID-19.
Sengul F; Ozturk B; Vatansev H
Am J Stem Cells; 2021; 10(5):79-89. PubMed ID: 35103115
[TBL] [Abstract][Full Text] [Related]
30. Multi-drug Treatment for COVID-19-induced Acute Respiratory Distress Syndrome.
Ohe M
Turk J Pharm Sci; 2022 Feb; 19(1):101-103. PubMed ID: 35227056
[TBL] [Abstract][Full Text] [Related]
31. Evolutionarily Conserved Long Non-coding RNA Regulates Gene Expression in Cytokine Storm During COVID-19.
Morenikeji OB; Bernard K; Strutton E; Wallace M; Thomas BN
Front Bioeng Biotechnol; 2020; 8():582953. PubMed ID: 33520952
[TBL] [Abstract][Full Text] [Related]
32. Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease.
Chiang CC; Korinek M; Cheng WJ; Hwang TL
Front Pharmacol; 2020; 11():572009. PubMed ID: 33162887
[TBL] [Abstract][Full Text] [Related]
33. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
34. Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol.
Capochiani E; Frediani B; Iervasi G; Paolicchi A; Sani S; Roncucci P; Cuccaro A; Franchi F; Simonetti F; Carrara D; Bertaggia I; Nasso D; Riccioni R; Scolletta S; Valente S; Conticini E; Gozzetti A; Bocchia M
Front Med (Lausanne); 2020; 7():466. PubMed ID: 32850921
[No Abstract] [Full Text] [Related]
35. Extracorporeal Hemoperfusion as a Potential Therapeutic Option for Severe COVID-19 patients; a Narrative Review.
Safari S; Salimi A; Zali A; Jahangirifard A; Bastanhagh E; Aminnejad R; Dabbagh A; Lotfi AH; Saeidi M
Arch Acad Emerg Med; 2020; 8(1):e67. PubMed ID: 33134963
[TBL] [Abstract][Full Text] [Related]
36. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
37. Severe acute respiratory syndrome-Coronavirus-2 infection: A review of the clinical-pathological correlations of Coronavirus disease-19 in children.
Teo JTR; Abidin NH; Cheah FC
Malays J Pathol; 2020 Dec; 42(3):349-361. PubMed ID: 33361715
[TBL] [Abstract][Full Text] [Related]
38. Prospects of plasmapheresis for patients with severe COVID-19.
Gilmutdinova IR; Yakovlev MY; Eremin PS; Fesun AD
Eur J Transl Myol; 2020 Sep; 30(3):9165. PubMed ID: 33117508
[TBL] [Abstract][Full Text] [Related]
39. Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications.
Loganathan S; Athalye SN; Joshi SR
Expert Opin Biol Ther; 2020 Sep; 20(9):1025-1031. PubMed ID: 32700604
[TBL] [Abstract][Full Text] [Related]
40. Fatal Gets More Fatal: A COVID-19 Infection With Macrophage Activation Syndrome.
Aydin Y; Vemuri B; Vajta Gomez JP; Challa PK; Zhang H
Cureus; 2022 Jun; 14(6):e25591. PubMed ID: 35795500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
